Cost-effectiveness of artemisinin –naphthoquine versus artemether–lumefantrine for the treatment of uncomplicated malaria in Papua New Guinean children

A recent randomized trial showed that artemisinin –naphthoquine (AN) was non-inferior to artemether–lumefantrine (AL) for falciparum malaria and superior for vivax malaria in young Papua New Guinean children. T...

Source: Malaria Journal - October 30, 2017 Category: Infectious Diseases Authors: Brioni R. Moore, Wendy A. Davis, Philip M. Clarke, Leanne J. Robinson, Moses Laman and Timothy M. E. Davis Tags: Research Source Type: research